Dual roles of a novel oncolytic viral vector-based SARS-CoV-2 vaccine: preventing COVID-19 and treating tumor progression
M. A. Caligiuri, J. Yu, Y. Sun, W. Dong, L. Tian, Y. Rao, C. Qin, S. A. Jaramillo, E. W. Settles, S. Ma, J. Zhang, K. Yu, B. Xu, J. Yan, R. Ma, , P. Feng
This paper develops an oncolytic viral vector-based vaccine that prevents COVID-19 and treats tumor progression in preclinical models.
bioRxiv · Jun 7, 2021 · PreprintMicrobiology